aiwiki.page
English
Health / Medicine & Treatment / anatomic-pathology

Anatomic Pathology

Anatomic pathology diagnoses and characterizes disease through the examination of organs, tissues, and cells, integrating structural findings with clinical and molecular information.

48 keywords1 linked from6 not yet writtenWritten by AI
PathologyDiagnosisMedicineHistopathologyAnatomyHistologyInflammationFibrosisAnatomic P…

Anatomic pathology is the branch of pathology concerned with the structural changes produced by disease in organs, tissues, and cells. Its principal activities include examining surgical specimens and biopsies, interpreting cellular samples, and investigating disease after death. Findings are assessed with the unaided eye, microscopy, and specialized laboratory techniques, then integrated with clinical information to establish a diagnosis, characterize disease, and identify features relevant to treatment and prognosis.

The discipline connects biological mechanisms with practical decisions in medicine. A tissue examination may distinguish an inflammatory process from a malignant tumor, establish whether a lesion has been completely removed, identify transplant injury, or determine whether a tumor contains a treatment-associated molecular alteration. Anatomic pathology therefore extends beyond naming a disease: it provides a structured account of its location, extent, biological properties, and relationship to the specimen examined.

Its traditional foundation is morphological interpretation, but contemporary practice combines histopathology, cytopathology, immunologic methods, molecular analysis, and digital imaging. The boundaries between these activities and other laboratory specialties vary among countries and institutions.

Scope and conceptual foundations

Anatomic pathology studies disease in its spatial context. The arrangement of cells within a gland, the distribution of inflammatory cells around blood vessels, or the relationship of a tumor to an organ surface may be as important as the appearance of individual cells. Normal anatomy and histology provide the reference against which these changes are recognized. Pathologists evaluate architecture, cellular differentiation, nuclear features, extracellular material, and the pattern of injury, rather than interpreting any single abnormality in isolation.

Morphological changes represent a limited repertoire of tissue responses to many possible causes. Cell death, regeneration, inflammation, and fibrosis occur in numerous unrelated disorders. Granulomatous inflammation, for example, can accompany infection, immune-mediated disease, or foreign material. Its recognition narrows the possibilities but does not necessarily identify the cause. Conversely, one disease may produce different appearances at different stages or in different organs. Interpretation therefore requires information about symptoms, imaging, laboratory findings, prior treatment, and the anatomical site sampled.

Anatomic pathology is conventionally distinguished from clinical pathology, which encompasses laboratory disciplines such as clinical chemistry, hematology, microbiology, and transfusion medicine. This division is organizational rather than absolute. Bone marrow disease may require tissue sections, blood smears, flow cytometry, and genetic testing; an infection may be investigated through tissue stains, culture, and molecular assays. Molecular pathology also spans both branches. In the United Kingdom, “histopathology” commonly names a specialty covering much of the work called anatomic pathology in North America, although training and service boundaries differ.

The major practice areas are surgical pathology, cytopathology, and autopsy pathology. Organ-based subspecialties include gastrointestinal pathology, dermatopathology, neuropathology, renal pathology, gynecologic pathology, and hematopathology. These areas differ in specimen handling and diagnostic methods as well as subject matter. Kidney biopsies, for instance, often require coordinated light microscopy, immunofluorescence, and electron microscopy, whereas many skin specimens are primarily evaluated in routinely stained sections.

A pathological diagnosis is an interpretation of the material actually available, not an unrestricted statement about the entire patient. A small biopsy may establish malignancy without showing its full extent; a negative sample may miss a nearby lesion. Reports consequently distinguish positive findings, adequately assessed negative findings, and questions that the specimen cannot resolve. This relationship between evidence and sampling is fundamental to the discipline.

Historical development

The emergence of anatomic pathology depended on a shift from explanations of illness based primarily on bodily fluids toward explanations grounded in observable lesions. Earlier medical traditions included anatomical observations, but systematic comparison of symptoms during life with findings after death established a more durable investigative framework. Giovanni Battista Morgagni’s De Sedibus et Causis Morborum per Anatomen Indagatis, published in 1761, organized numerous clinicopathological observations around the location and causes of disease. It helped establish organs as sites in which illness could be anatomically investigated.

Around the beginning of the nineteenth century, Xavier Bichat emphasized tissues rather than organs as fundamental units of disease. His investigations largely relied on dissection and physical observation rather than microscopy. This distinction mattered because an organ contains several tissue types that can be affected differently. During the nineteenth century, improvements in microscopes, tissue preparation, and staining made cellular investigation increasingly practical. Rudolf Virchow’s 1858 lectures on cellular pathology consolidated the view that disease processes should be understood through changes in cells, although this transformation involved contributions from many investigators.

The development of routine tissue processing made microscopy a reproducible clinical service. Fixation preserved specimens, embedding media supported thin sectioning, and microtomes produced sections suitable for transmitted-light examination. Formaldehyde entered histological practice in the late nineteenth century, and paraffin embedding became a central processing method. These techniques allowed small tissue samples to be retained, sectioned repeatedly, and compared with previously documented disease patterns. Surgical pathology grew alongside advances in surgery, anesthesia, and hospital organization, as more tissue became available from living patients.

Cytological diagnosis expanded substantially during the twentieth century. George Papanicolaou’s work, including the 1943 monograph with Herbert Traut, helped establish examination of exfoliated cervical cells as a method of detecting cervical disease. Needle aspiration techniques subsequently developed into an important means of investigating palpable and image-detected lesions. Meanwhile, immunofluorescence and later enzyme-based immunohistochemical methods made it possible to visualize selected antigens within cells and tissues, linking morphology to biochemical identity.

Late twentieth- and early twenty-first-century developments added molecular classification and predictive testing. Chromosomal abnormalities, gene rearrangements, and sequence variants became defining features of some disease entities rather than merely supplementary observations. Whole-slide scanning subsequently enabled tissue sections to be reviewed as digital images. These changes expanded the evidence available to pathologists without eliminating the need to assess specimen quality, anatomical relationships, and the clinical meaning of a result.

Specimen collection, processing, and preservation

The diagnostic process begins before a specimen reaches the laboratory. The clinical question determines what material is collected and how it must be handled. An endoscopic mucosal biopsy, a needle core from a mass, and an entire resected organ provide different kinds of information. Accurate identification, anatomical labeling, and relevant clinical details are essential because a technically excellent section from a mislabeled or poorly localized specimen can still produce a clinically misleading interpretation.

Most routine tissue specimens are placed in neutral buffered formalin. Commercial “10% neutral buffered formalin” contains approximately 4% formaldehyde; the terminology refers to dilution of the original formalin stock solution. Fixation stabilizes tissue partly through chemical cross-linking, preserving architecture while also modifying proteins and nucleic acids. Delay before fixation, specimen thickness, and fixation duration can affect morphology and ancillary testing. Some specimens require different handling: material for microbiological culture must remain suitable for organism recovery, and fresh tissue may be needed for flow cytometry or selected molecular investigations.

During gross examination, the specimen is described, measured, and systematically sampled. The pathologist or appropriately trained laboratory professional identifies lesions, records their relationships to anatomical landmarks, and selects representative tissue. Surgical margins may be marked with colored inks so that their relationship to a lesion remains recognizable microscopically. Large specimens cannot ordinarily be examined in their entirety, making sampling strategy central to diagnostic reliability. Small biopsies, by contrast, are usually submitted completely.

Routine processing removes water, replaces it with a clearing agent, and infiltrates the tissue with paraffin wax. Sections commonly about 3–5 micrometers thick are cut with a microtome and placed on glass slides. Hematoxylin and eosin staining provides the standard initial view: nuclei appear predominantly blue-purple, while cytoplasm and many extracellular components appear in shades of pink. Additional levels through a paraffin block may reveal a focal lesion or clarify its relationship to surrounding structures.

Processing can introduce artifacts. Forceps may crush delicate cells, electrocautery can obscure tissue at a cut edge, and incomplete fixation may distort nuclear detail. Bone often requires decalcification before sectioning, but some decalcifying agents impair antigen detection or nucleic-acid analysis. Such effects are not merely cosmetic: they may limit what can be concluded from the sample.

Stored paraffin blocks and slides form a diagnostic archive. They permit later review, additional staining, and some retrospective molecular tests. Preservation practices must balance clinical needs, regulatory requirements, confidentiality, and the finite amount of tissue available. In very small biopsies, successive tests can exhaust the specimen, so allocation of material is part of the diagnostic plan.

Surgical pathology and tissue-based diagnosis

Surgical pathology examines tissue removed from living patients, ranging from tiny mucosal fragments to complex multiorgan resections. The task may be to identify an unexplained lesion, confirm a suspected disease, assess the result of treatment, or document the extent of a known neoplasm. Interpretation generally proceeds from low-power architectural assessment to higher-power examination of cellular details. The resulting pattern is compared with a differential diagnosis and refined using clinical information and, when necessary, ancillary tests.

In cancer, several distinct questions must be separated. Histological type describes the kind of tumor; grade estimates specified microscopic features associated with biological behavior; stage describes anatomical extent. A well-differentiated tumor may resemble its tissue of origin closely, whereas a poorly differentiated tumor may require additional methods to establish lineage. Grading systems are disease-specific and cannot be transferred indiscriminately between organs. Staging commonly uses the TNM staging system, but the definitions of tumor extent, nodal involvement, and distant spread depend on the tumor site.

Resection specimens can reveal invasion, vascular or lymphatic involvement, the status of surgical margins, and involvement of regional lymph nodes. These findings help distinguish a localized lesion from one that has extended into neighboring structures or produced metastases. Margin assessment depends on orientation, sampling, and the operation performed. “No tumor at the examined margin” is not equivalent to proof that every possible microscopic focus elsewhere in the patient has been excluded.

Intraoperative consultation provides information while an operation is in progress. A frozen section is produced by rapidly freezing tissue and cutting it in a cryostat. It may help identify a lesion, assess selected margins, or determine whether diagnostic tissue has been obtained. Frozen sections are faster than routine paraffin processing but often show inferior morphology and freezing artifacts. Some questions are deferred until permanent sections or specialized studies are available. The appropriate intraoperative answer may therefore be narrower than the eventual final diagnosis.

Non-neoplastic surgical pathology is equally substantial. Intestinal biopsies may show changes associated with celiac disease or patterns relevant to inflammatory bowel disease. Liver biopsies may characterize injury and scarring, while kidney biopsies distinguish patterns of glomerular, vascular, and tubulointerstitial disease. In organ transplantation, tissue examination can help identify rejection, infection, recurrent disease, and drug-associated injury. These interpretations depend on distributions of damage and combinations of findings rather than on a universal microscopic sign.

Cytopathology and minimally invasive sampling

Cytopathology investigates disease through individual cells, small cell groups, and associated background material. Samples may consist of spontaneously shed cells, cells collected by brushing or washing a surface, or cells aspirated through a needle. Common sources include the cervix, urine, respiratory tract, thyroid, lymph nodes, and body-cavity fluids. Compared with many tissue biopsies, cytological sampling can be less invasive and can provide rapid diagnostic information, although the amount of preserved architecture is usually more limited.

Fine-needle aspiration collects material through a narrow needle, sometimes guided by ultrasonography, computed tomography, or endoscopic imaging. The aspirate may be spread directly onto slides, placed in a liquid preservative, or processed into a cell block. A cell block concentrates material so that sections can be prepared much like small tissue sections, enabling immunohistochemistry and some molecular assays. Rapid on-site evaluation can assess whether useful material has been obtained and help direct additional samples toward microbiology, flow cytometry, or other investigations.

Cytological interpretation emphasizes nuclear size and shape, chromatin pattern, nucleoli, cytoplasmic features, cell cohesion, and the background. Necrosis, mucin, inflammatory cells, and extracellular substances can provide important clues. However, reactive cells can show striking atypia, and some malignant cells can look deceptively bland. The distinction between a benign reaction and malignancy therefore requires pattern recognition informed by specimen type, clinical context, and the known limitations of the method.

Cervical cytology illustrates the connection between cellular interpretation and screening. It identifies cellular abnormalities associated with precancerous and malignant cervical disease. Testing for human papillomavirus has changed screening strategies, with primary HPV testing used in many programs. Cytology nevertheless retains roles in specified screening and follow-up pathways. Its categories describe the observed cellular findings and do not necessarily establish the complete histological extent of an underlying lesion.

Standardized reporting systems exist for cervical, thyroid, urinary, salivary-gland, and other cytological specimens. These systems distinguish inadequate samples, benign findings, indeterminate categories, suspicious findings, and malignancy using site-specific criteria. Indeterminate categories communicate a real limitation of the evidence rather than simply an unfinished interpretation. For example, thyroid follicular carcinoma may require demonstration of capsular or vascular invasion, a relationship that cannot reliably be established from dispersed aspirated cells alone. Cytopathology is therefore complementary to tissue examination: it can establish many diagnoses efficiently, while other questions require preserved architecture or a larger specimen.

Immunohistochemistry and molecular characterization

Immunohistochemistry uses antibodies to detect selected antigens in tissue sections. The bound antibody is visualized through a detection system, commonly producing a colored deposit at the site of the target. This preserves the relationship between a molecular signal and the tissue structure. Pathologists assess not only whether staining is present but also which cells stain, whether staining is nuclear, cytoplasmic, or membranous, and whether its intensity and distribution fit the diagnostic question.

Panels are usually more informative than isolated markers. Keratins support epithelial differentiation in an appropriate setting; other markers help identify lymphoid, melanocytic, muscular, or other lineages. None of these broad associations eliminates exceptions. A tumor may lose an expected antigen or express an unexpected one, and non-neoplastic cells within a specimen may stain strongly. Positive and negative controls, proper localization, and concordance with morphology are essential to interpretation.

Some stains also provide prognostic or treatment-related information. Estrogen-receptor and HER2 assessment in breast cancer are established examples. Mismatch-repair protein staining can identify patterns suggesting mismatch-repair deficiency, relevant to tumor classification, hereditary-risk evaluation, and certain treatment contexts. Loss of a protein does not by itself prove Lynch syndrome, because sporadic mechanisms can produce similar findings. PD-L1 testing likewise depends on the tumor type, assay, scoring method, and treatment setting rather than on a single universal threshold.

Molecular methods examine alterations in DNA, RNA, or chromosomal organization. In situ hybridization preserves spatial information while detecting selected sequences or copy-number changes. Polymerase chain reaction and sequencing methods can identify defined variants, and broader sequencing panels can investigate multiple genes simultaneously. Rearrangements and mutations may support the classification of lymphoma, soft-tissue tumors, and other neoplasms, while selected alterations in lung cancer can identify eligibility for particular targeted treatments.

Tissue quality constrains all these methods. A sample containing only a small proportion of tumor may yield a falsely negative result if the alteration falls below the assay’s detection limit. Pathologists may mark tumor-rich areas for dissection, estimate tumor content, and identify necrotic or otherwise unsuitable material. Fixation and processing also affect assay performance. A biomarker result is therefore an interpretation of a validated test performed on a particular specimen, not an unlimited description of the disease.

This integration underlies precision medicine and the use of a companion diagnostic. Molecular findings supplement morphology and clinical information; they do not automatically supersede either, and not every detected alteration has established diagnostic or therapeutic significance.

Autopsy pathology and investigation of death

An autopsy is a systematic examination after death to investigate disease, injury, and their consequences. A hospital or clinical autopsy primarily addresses medical questions, such as the cause of an unexplained deterioration, the distribution of disease, or complications of treatment. A medicolegal autopsy addresses questions arising under the relevant legal jurisdiction. The two activities share anatomical methods but differ in authority, consent arrangements, documentation, and the handling of evidence.

A complete examination may include external inspection, examination of organs in situ, dissection, tissue sampling, and ancillary testing. The sequence and extent depend on the question and the authorization governing the examination. Selected cases require microbiology, toxicology, genetic analysis, or specialized neuropathological assessment. Postmortem imaging can add information about fractures, gas distribution, foreign objects, and other findings, but its ability to replace dissection varies with the condition being investigated.

An important task is to distinguish the underlying cause of death from intermediate events and terminal physiological mechanisms. For example, coronary atherosclerosis may lead to myocardial infarction and then fatal cardiac dysfunction. A statement such as “cardiac arrest” describes a terminal event without necessarily identifying the disease responsible. Anatomical findings are interpreted alongside the clinical course, circumstances of death, and other investigations when completing or informing a death certificate.

Forensic pathology additionally addresses matters such as injury interpretation, identification, and the relationship between findings and the circumstances of death. Cause of death and manner of death are separate determinations: the former identifies the disease or injury responsible, whereas the latter is a jurisdiction-dependent classification of circumstances. Not every unexplained death produces a definitive anatomical diagnosis. Fatal arrhythmias and some metabolic disturbances may leave no specific structural lesion, making ancillary evidence especially important.

Autopsy also supports medical education, disease surveillance, and evaluation of diagnostic accuracy. It can reveal unsuspected infections, thromboembolism, treatment complications, or the true distribution of a malignancy. Such observations contribute to public health, particularly when a new disease or unusual exposure is being investigated. They also provide feedback on the strengths and limits of diagnosis during life.

Postmortem change complicates interpretation. Autolysis, decomposition, redistribution of chemicals, and bacterial growth can alter tissues and laboratory results. The interval after death, storage conditions, resuscitation, and treatment history therefore matter. Ethical and legal requirements concerning authorization, retained tissue, cultural practices, and communication with relatives are integral to autopsy practice, rather than administrative details separate from the examination.

Reporting, diagnostic uncertainty, and quality assurance

The pathology report is the principal communication between the laboratory and the clinical team. It ordinarily identifies the specimen and procedure, records the diagnosis, and includes relevant descriptive findings, ancillary results, and limitations. Cancer resection reports often use structured or synoptic formats so that essential items—such as tumor type, size, grade, extent, margins, and lymph-node findings—are presented consistently. Standardization improves completeness and makes clinically significant information easier to locate.

Diagnostic certainty varies with the specimen and the disease. Some lesions have highly characteristic features, while others lie along biological and morphological continua. Terms such as “consistent with,” “suspicious for,” or “cannot exclude” communicate different degrees of confidence, although their meaning can vary unless supported by a clear explanation. An inadequate sample is distinct from a negative sample: the former does not provide sufficient evidence for the intended assessment. Similarly, absence of a feature in limited tissue is not always evidence that the feature is absent from the lesion as a whole.

Interpretive variation can arise from sampling, technical quality, classification criteria, and observer judgment. Specialist consultation, review of additional sections, and correlation with imaging or prior specimens can resolve some discrepancies. Others reflect genuine uncertainty at a diagnostic boundary. Histological grading and assessment of some borderline lesions are particularly dependent on explicit criteria and consistent application. Multidisciplinary conferences provide a setting for reconciling pathological findings with clinical and radiological evidence without treating any one source as infallible.

Quality assurance spans the preanalytical, analytical, and postanalytical phases. Preanalytical controls address identification, transport, fixation, and accessioning. Analytical controls include instrument maintenance, stain quality, assay validation, and monitoring of test performance. Postanalytical controls address report accuracy, timely communication, amendments, and documentation of important discussions. These activities contribute directly to patient safety, because errors can originate in specimen handling and communication as well as interpretation.

Performance assessment may include external proficiency testing, audits, review of discordant diagnoses, and comparison of cytological findings with subsequent histology. Measures such as diagnostic sensitivity and specificity depend on the population, specimen quality, disease definition, and reference standard; they are not fixed properties of pathology as a whole. A test validated for one specimen type or clinical use cannot automatically be assumed valid for another.

Reporting also entails stewardship of tissue and information. Additional testing consumes material, and molecular studies can reveal findings with implications beyond the immediate diagnosis. Confidentiality, authorized access, and responsible communication are especially important when specimens and reports are shared between institutions or used in research.

Digital pathology, computation, and research

Digital pathology represents tissue slides and associated information in digital form. Whole-slide scanners capture a glass slide as a navigable, high-resolution image that can be viewed at different magnifications. Digital systems support remote consultation, education, archiving, image analysis, and, where appropriately validated, primary diagnosis. A functioning digital service requires more than a scanner: image quality, display performance, network capacity, storage, specimen identifiers, and integration with laboratory records all affect reliability.

Digitization changes how slides can be accessed and compared, but it does not remove errors originating earlier in the workflow. A scan cannot recover tissue that was not sampled, correct an incorrectly labeled block, or restore an antigen damaged during processing. Scanning itself may introduce problems, including out-of-focus regions, missed tissue fragments, or stitching artifacts. Validation must therefore address the intended diagnostic use and the complete workflow rather than assuming that any technically readable image is sufficient.

Computational methods can measure stained areas, count cells, locate candidate abnormalities, and characterize tissue patterns. Machine-learning systems, including deep-learning models, can be trained to detect tumor, classify selected lesions, or quantify particular biomarkers. Their performance depends on the training data, reference annotations, case selection, scanner characteristics, and evaluation design. An algorithm tested on a narrowly selected dataset may perform differently when confronted with uncommon tumors, treatment effects, poor-quality sections, or material from another institution.

Clinical assessment must consider the interaction between software and human interpretation. A detection tool may improve recognition of small abnormalities but also generate false alerts; a scoring system may improve consistency while remaining vulnerable to staining variation. Independent evaluation, monitoring after deployment, and attention to performance across different patient populations and laboratories are therefore important. Artificial intelligence in pathology is not a single diagnostic method but a collection of tools with distinct purposes and limitations.

Research increasingly links images with genomic, transcriptomic, and clinical data. Spatial methods investigate molecular signals while retaining their location within tissue, helping characterize tumor–immune interactions and regional variation. Different areas of a tumor may contain different cellular populations or molecular alterations, so a single section or biopsy may provide only a partial account. Archived tissue collections enable large retrospective studies, although fixation, historical treatment differences, and incomplete clinical data can constrain interpretation.

Digital networks also create obligations concerning data privacy, cybersecurity, access control, and data retention. Slide images can be accompanied by identifying labels and linked clinical information. Sharing material for consultation, research, or algorithm development consequently requires governance of both the images and their associated records, as well as documentation of how specimens and diagnostic annotations were obtained.